FDA Approves Drug to Prevent Migraines
Aimovig was approved on Thursday, become the first medicine of its kind — a once a month injection used to block a key molecule that starts migraines. In clinical trials, the FDA said most people experienced one less migraine a month after taking Aimovig. Research...
Read More